<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="of myocarditis, as well as due to the application of" exact="chloroquine" post="and hydroxychloroquine, especially if combined with azithromycin. This therapy"/>
 <result pre="2020 in the Lancet, did not prove the benefit of" exact="hydroxychloroquine" post="or chloroquine used as monotherapy or in combination with"/>
 <result pre="the Lancet, did not prove the benefit of hydroxychloroquine or" exact="chloroquine" post="used as monotherapy or in combination with second-generation macrolides,"/>
 <result pre="chloroquine used as monotherapy or in combination with second-generation macrolides," exact="azithromycin" post="or clarithromycin. At the same time, there were ventricular"/>
 <result pre="dehydrogenase (LDH), CRP, interleukin 1, interleukin 6, tumor necrosis factor" exact="alpha" post="(TNF-alpha) and lymphopenia (12). A significant number of people"/>
 <result pre="namely remdesivir, lopinavir/ritonavir, lopinavir/ritonavir in combination with interferon beta-1; and" exact="chloroquine" post="or hydroxychloroquine. 14. REMDESIVIR I COVID-19 Remdesivir is the"/>
</results>
